Novo Nordisk A/S announced a share repurchase program initiated on May 6, 2024, aiming to buy back up to DKK 20 billion of shares over 12 months, having repurchased 10,820,537 B shares for DKK 9.5 billion by July 26, 2024. As of the latest update on July 29, 2024, the company owns 12,186,327 B shares as treasury shares, representing 0.3% of its capital.